BioSpace News Archive

Global Acetabular Prostheses Market 2019-2023| Advances in Acetabular Prostheses to Boost the Market| Technavio

New market research study by Technavio on the global acetabular prostheses market projects the market to grow at a CAGR of more than 3% during the period 2019-2023.

May 14, 2019
·
4 min read
FDA grants clearance for a heart murmur detection solution on a personal mobile device

- eMurmur® today announced that its flagship “eMurmur ID” solution has received FDA clearance, enabling a new era in heart murmur detection. eMurmur ID is a mobile and cloud solution which operates in conjunction with a 3rd party electronic stethoscope.

May 14, 2019
·
2 min read
Business

i2i Welcomes Zack Klint as Vice President, Client Success

i2i Population Health, a leader in actionable population health solutions, has named Zack Klint to take ownership of its client success team.

May 14, 2019
·
1 min read
Pharm Country

Muscular Dystrophy Association Awards 26 Grants Totaling More Than $7.5 Million for Neuromuscular Disease Research

The Muscular Dystrophy Association (MDA) announced today the awarding of 26 new MDA grants totaling more than $7.5 million toward research focused on a variety of rare neuromuscular diseases

May 14, 2019
·
8 min read
Business

FHE Health Is Now a Provider with VA Partner TriWest Healthcare Alliance

FHE Health has contracted with TriWest Healthcare Alliance, a partner of the Department of Veterans Affairs serving America’s veterans and military community in administering high-quality healthcare.

May 14, 2019
·
2 min read
Business

Anti-Contraband Spokesperson Condemns the Federal Government for Making Legal Packaging Same as Illegal

Today, Gary Grant, the National Spokesperson for the National Coalition Against Contraband Tobacco (NCACT), condemned the Federal Government for moving ahead with plain and standardized packaging, despite clear examples internationally of increases in illicit tobacco due to similar policies.

May 14, 2019
·
2 min read
Drug Development

VALBIOTIS Will Present the Results of the International Phase IIA Clinical Study of VALEDIA® before 31 July 2019

VALBIOTIS (FR0013254851 – ALVAL / PEA/SME eligible) (Paris:ALVAL), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the completion of the international Phase IIA clinical study evaluating VALEDIA®

May 14, 2019
·
4 min read
Business

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore

At a ceremony in Singapore, Varian announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact single-room proton therapy system at Biopolis, an international biomedical research hub.

May 14, 2019
·
2 min read
Business

Luciole Medical AG Appoints Dr. C.A. Izeboud to its Board of Directors

Dr. C.A. (Oscar) Izeboud, Managing Director at NIBC Bank N.V., strengthens Board with first-hand experience in medtech and financial markets

May 14, 2019
·
3 min read
Deals

Encision Reports Fourth Quarter Fiscal Year 2019 Results

Encision Inc. announced financial results for its fiscal 2019 fourth quarter that ended March 31, 2019.

May 14, 2019
·
4 min read